These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18502751)

  • 1. alpha-Synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation: understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis.
    Zhang NY; Tang Z; Liu CW
    J Biol Chem; 2008 Jul; 283(29):20288-98. PubMed ID: 18502751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Synuclein reduces proteasomal inhibition by alpha-synuclein but not gamma-synuclein.
    Snyder H; Mensah K; Hsu C; Hashimoto M; Surgucheva IG; Festoff B; Surguchov A; Masliah E; Matouschek A; Wolozin B
    J Biol Chem; 2005 Mar; 280(9):7562-9. PubMed ID: 15591046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation.
    Chen JY; Zhu Q; Cai CZ; Luo HB; Lu JH
    Phytomedicine; 2022 Jul; 101():154125. PubMed ID: 35525236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function.
    Snyder H; Mensah K; Theisler C; Lee J; Matouschek A; Wolozin B
    J Biol Chem; 2003 Apr; 278(14):11753-9. PubMed ID: 12551928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome.
    Emmanouilidou E; Stefanis L; Vekrellis K
    Neurobiol Aging; 2010 Jun; 31(6):953-68. PubMed ID: 18715677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease.
    Liu CW; Giasson BI; Lewis KA; Lee VM; Demartino GN; Thomas PJ
    J Biol Chem; 2005 Jun; 280(24):22670-8. PubMed ID: 15840579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
    Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
    Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation.
    Alves da Costa C; Dunys J; Brau F; Wilk S; Cappai R; Checler F
    J Biol Chem; 2006 Apr; 281(14):9824-31. PubMed ID: 16464850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.
    Tofaris GK; Layfield R; Spillantini MG
    FEBS Lett; 2001 Nov; 509(1):22-6. PubMed ID: 11734199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of cleavage of alpha-synuclein by the 20S proteasome and modulation of its degradation by the RedOx state of the N-terminal methionines.
    Alvarez-Castelao B; Goethals M; Vandekerckhove J; Castaño JG
    Biochim Biophys Acta; 2014 Feb; 1843(2):352-65. PubMed ID: 24315858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and L-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson's disease.
    Kumar V; Singh D; Singh BK; Singh S; Mittra N; Jha RR; Patel DK; Singh C
    Mol Cell Biochem; 2018 Jul; 444(1-2):149-160. PubMed ID: 29198021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Synuclein fate: proteasome or autophagy?
    Engelender S
    Autophagy; 2012 Mar; 8(3):418-20. PubMed ID: 22361583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein.
    Dorval V; Fraser PE
    J Biol Chem; 2006 Apr; 281(15):9919-24. PubMed ID: 16464864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis.
    Chau KY; Ching HL; Schapira AH; Cooper JM
    J Neurochem; 2009 Aug; 110(3):1005-13. PubMed ID: 19493164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome.
    Petroi D; Popova B; Taheri-Talesh N; Irniger S; Shahpasandzadeh H; Zweckstetter M; Outeiro TF; Braus GH
    J Biol Chem; 2012 Aug; 287(33):27567-79. PubMed ID: 22722939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-Synuclein budding yeast model: toxicity enhanced by impaired proteasome and oxidative stress.
    Sharma N; Brandis KA; Herrera SK; Johnson BE; Vaidya T; Shrestha R; Debburman SK
    J Mol Neurosci; 2006; 28(2):161-78. PubMed ID: 16679556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock proteins reduce alpha-synuclein aggregation induced by MPP+ in SK-N-SH cells.
    Fan GH; Zhou HY; Yang H; Chen SD
    FEBS Lett; 2006 May; 580(13):3091-8. PubMed ID: 16678164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome impairment by α-synuclein.
    Zondler L; Kostka M; Garidel P; Heinzelmann U; Hengerer B; Mayer B; Weishaupt JH; Gillardon F; Danzer KM
    PLoS One; 2017; 12(9):e0184040. PubMed ID: 28945746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Ubiquitin-Proteasome and Autophagy-Lysosome Pathways in α-Synuclein Aggregate Clearance.
    Sahoo S; Padhy AA; Kumari V; Mishra P
    Mol Neurobiol; 2022 Sep; 59(9):5379-5407. PubMed ID: 35699874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein.
    McKinnon C; De Snoo ML; Gondard E; Neudorfer C; Chau H; Ngana SG; O'Hara DM; Brotchie JM; Koprich JB; Lozano AM; Kalia LV; Kalia SK
    Acta Neuropathol Commun; 2020 Feb; 8(1):17. PubMed ID: 32059750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.